Drägerwerk AG & Co. KGaA (0MT8) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Ladies and gentlemen, welcome to the Q2 2025 earnings call. I am George, the course call operator. I would like to remind you that all participants will be in listen-only mode and the conference is being recorded. The presentation will be followed by Q&A session. You can register for questions at any time by pressing star and one on your telephone. For operator assistance, please press star and zero. The conference must not be recorded for publication or broadcast. At this time, it's my pleasure to hand over to Stefan Drager, CEO. Please go ahead. Yes, good afternoon, and thank you for joining our conference call and our financial results for the first half of 2025. And thank you all for your flexibility before rescheduling the course of one hour due to organizational reasons. Thank you. for being with us. I have with me today, Gerd Habeck-Lesko, CFO, as well as Tom Fischer and Nicola Thomas-Schmidt, both investor relations. We would like to take you through the results of the presentation that we made available on our webpage this morning. Following the presentation, we will open this floor to your questions. So let's get started on page five with the business highlights. stable net sales and a positive operating result, we achieved a solid business performance in the first half of 2025. At around 1.5 billion euro, net sales were nominally slightly below the prior year, but adjusted for currency effects, they slightly increased. On the other hand, Other than in the first half of 2024, growth was driven by the medical division instead of the safety department. Prices before interest and taxes could not keep up with net sales as our EBIT fell short of the prior year figure at just over 20 million euros. This was due particularly to the positive one-off effects in the ...